(Press-News.org) New research shows that all not mammals are created equal. In fact, this work shows that the animals most commonly used by scientists to study mammalian genetics -- mice -- develop unusually quickly and may not always be representative of embryonic development in other mammals. The study, published by Cell Press in the February 14 issue of the journal Developmental Cell, identifies significant differences in the timing of cell fate commitment during mouse and cattle embryonic development and raises important strategic implications for the generation of embryonic stem cells.
The placenta in mammals is formed from cells called trophectoderm that arise from the very first lineage decision made by the early embryo. Most trophectoderm research is performed on mice, as other mammals tend to be much harder to work with in a lab. In the mouse, the fate of trophoectoderm cells is sealed (committed) by the mid-blastocyst stage. This fate commitment is driven in part by repression of the stem cell factor Oct4.
"We were intrigued by previous observations that in mammals such as humans, cattle, pigs and rabbits Oct4 protein was not shut down in the trophoectoderm of late blastocyst embryos," explains senior author Dr. Peter L. Pfeffer from AgResearch Crown Research Institute in Hamilton, New Zealand. Using cattle as a non-rodent model system, Dr. Pfeffer and colleagues discovered that cattle trophoectoderm cells were committed to their fate much later than mouse cells, with Oct4 expression levels remaining strong for longer than in mice. In fact the authors identified the specific evolutionary changes in mouse DNA that make Oct4 behave differently in mice than in other mammals.
"Somewhat ironically, our studies in cattle led to new insight into Oct4 regulation in the mouse," explains Dr Pfeffer. "Such evolutionary differences in the regulation of the key stem cell gene Oct4 may explain the difficulty in embryonic stem cell derivation in mammals other than the mouse." Based on the fact that mouse embryos implant in the uterus at an earlier developmental stage than other mammals do, and therefore require earlier trophectoderm formation, the authors also speculate that the unusually rapid repression of Oct4 in mouse trophectoderm represented a key evolutionary step enabling early implantation.
"Establishing cattle as a second functional mammalian embryological model system challenges notions that mice are representative of either the earliest stages of mammalian development or of embryonic stem cell biology," concludes Dr. Pfeffer.
### END
Not so fast: Differences in the first embryonic cell lineage decision of mammals
New research shows that all not mammals are created equal
2011-02-15
ELSE PRESS RELEASES FROM THIS DATE:
Military/civilian medical experts turning attention to 'army' of injured civilians supporting wars
2011-02-15
After analyzing data on 2,155 private contractors, diplomats and other civilians supporting war efforts in Iraq and Afghanistan who were medically evacuated out of combat zones, researchers have found they are more likely to be evacuated for noncombat-related injuries, but more likely to return to work in-country after treatment for these conditions.
Still, the findings of the Johns Hopkins-led research team, published online in CMAJ, the journal of the Canadian Medical Association, note that 75 percent of the nonmilitary group medically evacuated from the war zones to ...
People at risk of diabetes offer clues toward novel drugs
2011-02-15
BOSTON – February 14, 2011 – Once people develop type 2 diabetes, high blood glucose levels alter their metabolism so much that it becomes difficult to sift through all the clues to find what might enable the disease. "To identify factors that play a primary role in disease susceptibility, we want to investigate people before they get to that point," says Mary-Elizabeth Patti, M.D. of Joslin Diabetes Center. By examining people across the spectrum of diabetes—from healthy to the full-blown disease—scientists in her lab have found a molecular pathway that offers novel targets ...
New anti-clotting drug added to recommendations for treating irregular heartbeat
2011-02-15
The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation, according to updated guidelines from the American College of Cardiology, American Heart Association and the Heart Rhythm Society.
The "Focused Update" — published in Circulation: Journal of the American Heart Association, Journal of the American College of Cardiology and HeartRhythm Journal — specifically updates the section on emerging antithrombotic agents in atrial fibrillation treatment guidelines released by the three organizations ...
A hunk of a target for treating breast cancer
2011-02-15
Among women with breast cancer, approximately 25% have a subtype that is characterized by high levels of expression of the protein HER2. HER2-positive breast cancer tends to be more aggressive than other breast cancer subtypes. Increased molecular understanding of why HER2-positive breast cancer is so aggressive could aid in the development of new therapeutics. By studying mouse models, a team of researchers, led by Lewis Chodosh, at the University of Pennsylvania School of Medicine, Philadelphia, has now identified a key role for the protein Hunk in the formation of tumors ...
New combination therapy for solid tumors?
2011-02-15
Most, if not all, solid tumors contain regions that are not well oxygenated. Tumor cells in these regions, which are known as hypoxic regions, are usually resistant to the death-inducing effects of chemotherapeutics. But now, Caroline Dive and colleagues, at Manchester University, United Kingdom, have identified a compound (ABT-737) that induces human cancer cells exposed to hypoxic conditions in vitro to undergo a form of cell death known as apoptosis. In addition, cells in hypoxic regions of human tumors xenografted in mice were susceptible to ABT-737–induced apoptotic ...
JCI online early table of contents: Feb. 14, 2011
2011-02-15
EDITOR'S PICK: A hunk of a target for treating breast cancer
Among women with breast cancer, approximately 25% have a subtype that is characterized by high levels of expression of the protein HER2. HER2-positive breast cancer tends to be more aggressive than other breast cancer subtypes. Increased molecular understanding of why HER2-positive breast cancer is so aggressive could aid in the development of new therapeutics. By studying mouse models, a team of researchers, led by Lewis Chodosh, at the University of Pennsylvania School of Medicine, Philadelphia, has now identified ...
X-rays show why van Gogh paintings lose their shine
2011-02-15
This release is available in French.
VIDEO:
A microsample is taken from the van Gogh painting "Bank of river Seine " on display at the van Gogh Museum in Amsterdam (Netherlands), and then analyzed at the X-rays microscope...
Click here for more information.
Scientists have identified a complex chemical reaction responsible for the degradation of two paintings by Vincent ...
Medicare costs in last 6 months of life driven by patient variables twice as much as geography
2011-02-15
A study by Mount Sinai School of Medicine finds that Medicare costs at the end of life are influenced more by patient characteristics, such as ability to function, the severity of the illness, and family support than by regional factors, such as the number of hospital beds available. The study will be published February 15 in The Annals of Internal Medicine.
"These new findings show that the reasons for wide variation in Medicare costs across the United States are much more complicated than previously thought," said lead author Amy Kelley, MD, Assistant Professor in ...
UC San Diego biologists gain new insights into brain circuit wiring
2011-02-15
Neurobiologists at UC San Diego have discovered new ways by which nerves are guided to grow in highly directed ways to wire the brain during embryonic development.
Their finding, detailed in a paper in the February 15 issue of the journal Developmental Cell, provides a critical piece of understanding to the longstanding puzzle of how the human brain wires itself into the complex networks that underlie our behavior.
The discovery concerns the movements of a highly sensitive and motile structure at the tips of growing nerves called a growth cone. For more than a century, ...
Less is more when prescribing acid suppressive drugs for non-ICU patients
2011-02-15
BOSTON – Over the last several decades, the prophylactic use of acid-suppressive medications to help prevent gastrointestinal bleeding (GI) in hospitalized patients has increased significantly, with some studies estimating that as many as 40 to 70 percent of all medical inpatients are given these drugs at some point during their hospitalization.
But, for patients who are not critically ill, the actual incidence of GI bleeding has not been well investigated.
Now, a study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) and reported in today's on-line ...
LAST 30 PRESS RELEASES:
How rice plants tell head from toe during early growth
Scientists design solar-responsive biochar that accelerates environmental cleanup
Construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases
Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy
DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer
Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model
Neg-entropy is the true drug target for chronic diseases
Oxygen-boosted dual-section microneedle patch for enhanced drug penetration and improved photodynamic and anti-inflammatory therapy in psoriasis
Early TB treatment reduced deaths from sepsis among people with HIV
Palmitoylation of Tfr1 enhances platelet ferroptosis and liver injury in heat stroke
Structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity
Therapeutic drug monitoring of biologics in inflammatory bowel disease: An evidence-based multidisciplinary guidelines
New global review reveals integrating finance, technology, and governance is key to equitable climate action
New study reveals cyanobacteria may help spread antibiotic resistance in estuarine ecosystems
Around the world, children’s cooperative behaviors and norms converge toward community-specific norms in middle childhood, Boston College researchers report
How cultural norms shape childhood development
University of Phoenix research finds AI-integrated coursework strengthens student learning and career skills
Next generation genetics technology developed to counter the rise of antibiotic resistance
Ochsner Health hospitals named Best-in-State 2026
A new window into hemodialysis: How optical sensors could make treatment safer
High-dose therapy had lasting benefits for infants with stroke before or soon after birth
‘Energy efficiency’ key to mountain birds adapting to changing environmental conditions
Scientists now know why ovarian cancer spreads so rapidly in the abdomen
USF Health launches nation’s first fully integrated institute for voice, hearing and swallowing care and research
Why rethinking wellness could help students and teachers thrive
Seabirds ingest large quantities of pollutants, some of which have been banned for decades
When Earth’s magnetic field took its time flipping
Americans prefer to screen for cervical cancer in-clinic vs. at home
Rice lab to help develop bioprinted kidneys as part of ARPA-H PRINT program award
Researchers discover ABCA1 protein’s role in releasing molecular brakes on solid tumor immunotherapy
[Press-News.org] Not so fast: Differences in the first embryonic cell lineage decision of mammalsNew research shows that all not mammals are created equal
